Serbian Oncology Patients Face Uncertainty Awaiting Innovative Therapy

More than two months after an agreement was announced between the Republic Health Insurance Fund (RFZO) and AstraZeneca for innovative therapy, oncology patients in Serbia remain in uncertainty as their disease progresses.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

n1-serbiaSerbian1d ago

Čekajući izbore i inovativnu terapiju: Onkološki pacijenti u neizvesnosti dok bolest napreduje, a vreme prolazi

Više od dva meseca pošto je objavljena vest da su Republički fond za zdravstveno osiguranje (RFZO) i kompanija Astrazeneka potpisali ugovor o nabavci

Read full article →

PERSPECTA

PERSPECTA

Serbian Oncology Patients Face Uncertainty Awaiting Innovative Therapy

Sources

Čekajući izbore i inovativnu terapiju: Onkološki pacijenti u neizvesnosti dok bolest napreduje, a vreme prolazi

Related Stories

Trump Considers Military Action Against Iran Amid Hormuz Blockade Discussions; UK Declines to Join

Philippine President Marcos Calls Congress to Special Session

Marcos Calls Special Session of Congress on June 17

Senator Tulfo Slams Misinformation on Blue Ribbon Committee Meeting

PERSPECTA